Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Zexian Zeng, Ph.D.

Profile Picture

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kumar S, Zeng Z, Bagati A, Tay RE, Sanz LA, Hartono SR, Ito Y, Abderazzaq F, Hatchi E, Jiang P, Cartwright ANR, Olawoyin O, Mathewson ND, Pyrdol JW, Li MZ, Doench JG, Booker MA, Tolstorukov MY, Elledge SJ, Chedin F, Liu XS, Wucherpfennig KW. CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor cells and T cells. Cancer Discov. 2021 Mar 11. PMID: 33707234.
    Citations:    Fields:    
  2. Gu SS, Zhang W, Wang X, Jiang P, Traugh N, Li Z, Meyer C, Stewig B, Xie Y, Bu X, Manos MP, Font-Tello A, Gjini E, Lako A, Lim K, Conway J, Tewari AK, Zeng Z, Sahu AD, Tokheim C, Weirather JL, Fu J, Zhang Y, Kroger B, Liang JH, Cejas P, Freeman GJ, Rodig S, Long HW, Gewurz BE, Hodi FS, Brown M, Liu XS. Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade. Cancer Discov. 2021 Jun; 11(6):1524-1541. PMID: 33589424.
    Citations:    Fields:    
  3. Zeng Z, Fu J, Cibulskis C, Jhaveri A, Gumbs C, Das B, Sanchez-Espiridion B, Janssens S, Taing L, Wang J, Lindsay J, Vilimas T, Zhang J, Tokheim C, Das Sahu A, Jiang P, Yan C, Duose DY, Cerami E, Chen L, Cohen D, Chen QR, Enos RA, Huang X, Lee JJ, Liu Y, Neuberg DS, Nguyen C, Patterson C, Sarkar S, Shukla SA, Tang M, Tsuji J, Uduman M, Wang X, Weirather JL, Yu J, Yu J, Zhang J, Zhang J, Meerzaman D, Thurin M, Futreal PA, Karlovich C, Gabriel SB, Wistuba II, Liu XS, Wu C. Cross-site concordance evaluation of tumor DNA and RNA sequencing platforms for the CIMAC-CIDC network. Clin Cancer Res. 2020 Dec 15. PMID: 33323402.
    Citations:    Fields:    
  4. Gu SS, Wang X, Hu X, Jiang P, Li Z, Traugh N, Bu X, Tang Q, Wang C, Zeng Z, Fu J, Meyer C, Zhang Y, Cejas P, Lim K, Wang J, Zhang W, Tokheim C, Sahu AD, Xing X, Kroger B, Ouyang Z, Long H, Freeman GJ, Brown M, Liu XS. Clonal tracing reveals diverse patterns of response to immune checkpoint blockade. Genome Biol. 2020 10 15; 21(1):263. PMID: 33059736.
    Citations:    Fields:    
  5. Zeng Z, Amin A, Roy A, Pulliam NE, Karavites LC, Espino S, Helenowski I, Li X, Luo Y, Khan SA. Preoperative magnetic resonance imaging use and oncologic outcomes in premenopausal breast cancer patients. NPJ Breast Cancer. 2020; 6:49. PMID: 33083528.
  6. Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020 07 02; 48(W1):W509-W514. PMID: 32442275.
    Citations: 96     Fields:    Translation:Cells
  7. Zeng Z, Vo A, Li X, Shidfar A, Saldana P, Blanco L, Xuei X, Luo Y, Khan SA, Clare SE. Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer. NPJ Breast Cancer. 2020; 6:24. PMID: 32566745.
    Citations: 1     
  8. Lee O, Sullivan ME, Xu Y, Rogers C, Muzzio M, Helenowski I, Shidfar A, Zeng Z, Singhal H, Jovanovic B, Hansen N, Bethke KP, Gann PH, Gradishar W, Kim JJ, Clare SE, Khan SA. Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate. Clin Cancer Res. 2020 01 01; 26(1):25-34. PMID: 31570566.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  9. Zeng Z, Zhao Y, Sun M, Vo AH, Starren J, Luo Y. Rich Text Formatted EHR Narratives: A Hidden and Ignored Trove. Stud Health Technol Inform. 2019 Aug 21; 264:472-476. PMID: 31437968.
    Citations:    Fields:    
  10. Zeng Z, Vo AH, Mao C, Clare SE, Khan SA, Luo Y. Cancer classification and pathway discovery using non-negative matrix factorization. J Biomed Inform. 2019 08; 96:103247. PMID: 31271844.
    Citations: 4     Fields:    Translation:HumansCells
  11. Zeng Z, Yao L, Roy A, Li X, Espino S, Clare SE, Khan SA, Luo Y. Identifying Breast Cancer Distant Recurrences from Electronic Health Records Using Machine Learning. J Healthc Inform Res. 2019; 3:283-299. PMID: 33225204.
    Citations: 1     
  12. Zimmerman LP, Reyfman PA, Smith ADR, Zeng Z, Kho A, Sanchez-Pinto LN, Luo Y. Early prediction of acute kidney injury following ICU admission using a multivariate panel of physiological measurements. BMC Med Inform Decis Mak. 2019 01 31; 19(Suppl 1):16. PMID: 30700291.
    Citations: 14     Fields:    Translation:Humans
  13. Mao C, Pan Y, Zeng Z, Yao L, Luo Y. Deep Generative Classifiers for Thoracic Disease Diagnosis with Chest X-ray Images. Proceedings (IEEE Int Conf Bioinformatics Biomed). 2018 Dec; 2018:1209-1214. PMID: 31341701.
    Citations: 1     
  14. Zeng Z, Espino S, Roy A, Li X, Khan SA, Clare SE, Jiang X, Neapolitan R, Luo Y. Using natural language processing and machine learning to identify breast cancer local recurrence. BMC Bioinformatics. 2018 Dec 28; 19(Suppl 17):498. PMID: 30591037.
    Citations: 5     Fields:    Translation:Humans
  15. Zeng Z, Deng Y, Li X, Naumann T, Luo Y. Natural Language Processing for EHR-Based Computational Phenotyping. IEEE/ACM Trans Comput Biol Bioinform. 2019 Jan-Feb; 16(1):139-153. PMID: 29994486.
    Citations: 18     Fields:    Translation:Humans
  16. Zeng Z, Jiang X, Li X, Wells A, Luo Y, Neapolitan R. Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls. PLoS One. 2018; 13(5):e0197064. PMID: 29768475.
    Citations: 1     Fields:    Translation:Humans
  17. Zeng Z, Li X, Espino S, Roy A, Kitsch K, Clare S, Khan S, Luo Y. Contralateral Breast Cancer Event Detection Using Nature Language Processing. AMIA Annu Symp Proc. 2017; 2017:1885-1892. PMID: 29854260.
    Citations: 5     Fields:    Translation:Humans
  18. Luo Y, Thompson WK, Herr TM, Zeng Z, Berendsen MA, Jonnalagadda SR, Carson MB, Starren J. Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. Drug Saf. 2017 11; 40(11):1075-1089. PMID: 28643174.
    Citations: 31     Fields:    Translation:Humans
  19. Zeng Z, Jiang X, Neapolitan R. Discovering causal interactions using Bayesian network scoring and information gain. BMC Bioinformatics. 2016 May 26; 17(1):221. PMID: 27230078.
    Citations: 7     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Zeng's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (58)
Co-Authors (22)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.